Clinical Trial Update: Efficacy and Safety of Kinetin 0.1% for Treatment of Skin Photoaging [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of kinetin 0.1% for treating cutaneous photoaging has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Photoaging

Drugs mentioned

• Kinetin 0.1% (kinetin)

Snippet

Sponsor: Makati Medical Center | Conditions: Cutaneous Photoaging | Phase 4 | Status: COMPLETED